Literature DB >> 25515236

Smooth muscle 22α facilitates angiotensin II-induced signaling and vascular contraction.

Xiao-Li Xie1, Xi Nie, Jun Wu, Fan Zhang, Li-Li Zhao, Yan-Ling Lin, Ya-Juan Yin, Hui Liu, Ya-Nan Shu, Sui-Bing Miao, Huan Li, Peng Chen, Mei Han.   

Abstract

UNLABELLED: Smooth muscle 22α (SM22α) is involved in stress fiber formation and enhances contractility in vascular smooth muscle cells (VSMCs). In many cases, SM22α acts as an adapter protein to assemble signaling complexes and regulate signaling, but whether SM22α regulates contractile signaling induced by angiotensin II (AngII) remains unclear. To address this issue, we established a hypertension model of Sm22α(-/-) mice, and demonstrated that hypertension induced by AngII was attenuated in Sm22α(-/-) mice. A decreased vasoconstriction was observed in aortic rings from Sm22α(-/-) mice. Furthermore, loss of SM22α resulted in a reduced contractile response to AngII in VSMCs in vitro. The phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2) induced by AngII was impaired following depletion of SM22α, in parallel with a reduced contractility. The decay of ERK1/2 activity was associated with increased expression of mitogen-activated protein kinase phosphatase 3 (MKP3). Inhibition of MKP3 activity rescued ERK1/2 activity. SM22α depletion caused an enhanced interaction of MKP3 with ERK1/2, and a reduced ubiquitination and degradation of MKP3. Knockdown of SM22α extended the half-life of MKP3. In conclusion, SM22α promotes AngII-induced contraction by maintenance of ERK1/2 signaling cascades through facilitating ubiquitination and degradation of MKP3. KEY MESSAGE: The vasoconstriction is attenuated in aortic rings from Sm22α(-/-) mice. MKP3 mediates dephosphorylation of ERK1/2 in AngII-induced VSMC contraction. SM22α inhibits the interaction of ERK1/2 with MKP3. SM22α promotes ubiquitination and degradation of MKP3. SM22α facilitates AngII-induced contraction by maintenance of ERK1/2 signaling.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25515236     DOI: 10.1007/s00109-014-1240-4

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  26 in total

1.  Role of pp60(c-src) and p(44/42) MAPK in ANG II-induced contraction of rat tonic gastrointestinal smooth muscles.

Authors:  Rajinder N Puri; Ya-Ping Fan; Satish Rattan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-08       Impact factor: 4.052

2.  Overexpression of SIRT1 in vascular smooth muscle cells attenuates angiotensin II-induced vascular remodeling and hypertension in mice.

Authors:  Peng Gao; Ting-Ting Xu; Jie Lu; Li Li; Jing Xu; De-Long Hao; Hou-Zao Chen; De-Pei Liu
Journal:  J Mol Med (Berl)       Date:  2013-12-19       Impact factor: 4.599

3.  Angiotensin II stimulates extracellular signal-regulated kinase activity in intact pressurized rat mesenteric resistance arteries.

Authors:  K Matrougui; Y E Eskildsen-Helmond; A Fiebeler; D Henrion; B I Levy; A Tedgui; M J Mulvany
Journal:  Hypertension       Date:  2000-10       Impact factor: 10.190

Review 4.  The dual-specificity MAP kinase phosphatases: critical roles in development and cancer.

Authors:  O Bermudez; G Pagès; C Gimond
Journal:  Am J Physiol Cell Physiol       Date:  2010-05-12       Impact factor: 4.249

5.  Postendocytic sorting of constitutively internalized dopamine transporter in cell lines and dopaminergic neurons.

Authors:  Jacob Eriksen; Walden Emil Bjørn-Yoshimoto; Trine Nygaard Jørgensen; Amy Hauck Newman; Ulrik Gether
Journal:  J Biol Chem       Date:  2010-06-15       Impact factor: 5.157

6.  ERK-mediated uterine artery contraction: role of thick and thin filament regulatory pathways.

Authors:  DaLiao Xiao; William J Pearce; Lawrence D Longo; Lubo Zhang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-05       Impact factor: 4.733

Review 7.  New insights on signaling cascades induced by cross-talk between angiotensin II and aldosterone.

Authors:  Catherine A Lemarié; Pierre Paradis; Ernesto L Schiffrin
Journal:  J Mol Med (Berl)       Date:  2008-03-27       Impact factor: 4.599

8.  SM22alpha is required for agonist-induced regulation of contractility: evidence from SM22alpha knockout mice.

Authors:  Hyun Dong Je; Uy Dong Sohn
Journal:  Mol Cells       Date:  2007-04-30       Impact factor: 5.034

9.  Ablation of SM22alpha decreases contractility and actin contents of mouse vascular smooth muscle.

Authors:  Asad Zeidan; Karl Swärd; Ina Nordström; Eva Ekblad; Janet C L Zhang; Michael S Parmacek; Per Hellstrand
Journal:  FEBS Lett       Date:  2004-03-26       Impact factor: 4.124

10.  Stretch activates human myometrium via ERK, caldesmon and focal adhesion signaling.

Authors:  Yunping Li; Maya Reznichenko; Rachel M Tribe; Philip E Hess; Michael Taggart; HakRim Kim; Jon P DeGnore; Samudra Gangopadhyay; Kathleen G Morgan
Journal:  PLoS One       Date:  2009-10-16       Impact factor: 3.240

View more
  10 in total

1.  Insulin-independent GLUT4 translocation in proliferative vascular smooth muscle cells involves SM22α.

Authors:  Li-Li Zhao; Fan Zhang; Peng Chen; Xiao-Li Xie; Yong-Qing Dou; Yan-Ling Lin; Lei Nie; Pin Lv; Dan-Dan Zhang; Xiao-Kun Li; Sui-Bing Miao; Ya-Juan Yin; Li-Hua Dong; Yu Song; Ya-Nan Shu; Mei Han
Journal:  J Mol Med (Berl)       Date:  2016-09-08       Impact factor: 4.599

2.  T3 inhibits the calcification of vascular smooth muscle cells and the potential mechanism.

Authors:  Xiaodan Chang; Baohong Zhang; Li Lihua; Zhichun Feng
Journal:  Am J Transl Res       Date:  2016-11-15       Impact factor: 4.060

3.  Deletion of SM22α disrupts the structure and function of caveolae and T-tubules in cardiomyocytes, contributing to heart failure.

Authors:  Jun Wu; Wei Wang; Yaomeng Huang; Haochen Wu; Jiabin Wang; Mei Han
Journal:  PLoS One       Date:  2022-07-18       Impact factor: 3.752

4.  Tripartite motif protein 11 (TRIM11), an oncogene for human lung cancer via the DUSP6-mediated ERK1/2 signaling pathway.

Authors:  Xiao-Lin Wang; Shi-Chun Lu; Chao Sun; Wei-Guo Jin; Yi-Wei Fan; Yu-Sheng Shu; Hong-Can Shi; Ling-Feng Min
Journal:  Cancer Biol Ther       Date:  2021-05-10       Impact factor: 4.742

5.  Immunoproteasome Inhibition Impairs T and B Cell Activation by Restraining ERK Signaling and Proteostasis.

Authors:  Christian Schmidt; Thilo Berger; Marcus Groettrup; Michael Basler
Journal:  Front Immunol       Date:  2018-10-26       Impact factor: 7.561

Review 6.  Inflammation and atherosclerosis: signaling pathways and therapeutic intervention.

Authors:  Peng Kong; Zi-Yang Cui; Xiao-Fu Huang; Dan-Dan Zhang; Rui-Juan Guo; Mei Han
Journal:  Signal Transduct Target Ther       Date:  2022-04-22

7.  PKN2 deficiency leads both to prenatal 'congenital' cardiomyopathy and defective angiotensin II stress responses.

Authors:  Jacqueline J T Marshall; Joshua J Cull; Hajed O Alharbi; May Zaw Thin; Susanna T E Cooper; Christopher Barrington; Hannah Vanyai; Thomas Snoeks; Bernard Siow; Alejandro Suáarez-Bonnet; Eleanor Herbert; Daniel J Stuckey; Angus J M Cameron; Fabrice Prin; Andrew C Cook; Simon L Priestnall; Sonia Chotani; Owen J L Rackham; Daniel N Meijles; Tim Mohun; Angela Clerk; Peter J Parker
Journal:  Biochem J       Date:  2022-07-15       Impact factor: 3.766

8.  Physiology and Proteomic Basis of Lung Adaptation to High-Altitude Hypoxia in Tibetan Sheep.

Authors:  Pengfei Zhao; Shaobin Li; Zhaohua He; Fangfang Zhao; Jiqing Wang; Xiu Liu; Mingna Li; Jiang Hu; Zhidong Zhao; Yuzhu Luo
Journal:  Animals (Basel)       Date:  2022-08-19       Impact factor: 3.231

9.  Neutrophil extracellular traps accelerate vascular smooth muscle cell proliferation via Akt/CDKN1b/TK1 accompanying with the occurrence of hypertension.

Authors:  Xinhui Fang; Ling Ma; Yanfu Wang; Fang Ren; Yanqiu Yu; Zhengwei Yuan; Hongquan Wei; Haipeng Zhang; Yingxian Sun
Journal:  J Hypertens       Date:  2022-08-03       Impact factor: 4.776

10.  Short-Term Angiotensin II Treatment Affects Large Artery Biomechanics and Function in the Absence of Small Artery Alterations in Mice.

Authors:  Arthur J A Leloup; Sofie De Moudt; Cor E Van Hove; Lindsey Dugaucquier; Zarha Vermeulen; Vincent F M Segers; Gilles W De Keulenaer; Paul Fransen
Journal:  Front Physiol       Date:  2018-05-16       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.